Carlos E. Orantes

Carlos E. Orantes has over 28 years of work experience in the clinical research and laboratory industry. Carlos E. is currently serving as the Chief Executive Officer of Alcanza Clinical Research since January 2022. Prior to this, they worked as the Executive Director Site Operations for The Americas Territory at Accelerated Enrollment Solutions from September 2020 to January 2022. Carlos E. has also held the position of Chief Executive Officer at AMPLIFY Clinical from April 2019 to June 2020 and at Accel Research Sites from May 2015 to April 2019. Earlier in their career, Carlos held leadership roles at Frontage Laboratories, Inc, Tech Council of Maryland, AVANZA Laboratories, Bridge Laboratories, Gene Logic Laboratories, and Covance Laboratories, where they gained extensive experience in operations, management, and quality assurance. Carlos E. has also contributed to the field of operational excellence and process improvement as a Six Sigma practitioner.

Carlos E. Orantes completed their undergraduate education from 1990 to 1994 at The George Washington University, where they earned a Bachelor of Science (B.S.) degree in Biology. Carlos E. later pursued further education in Six Sigma from 2003 to 2004 at the Six Sigma Academy, obtaining Greenbelt and Blackbelt certifications. Additionally, they completed their Master of Business Administration (MBA) degree at Old Dominion University from 2000 to 2002. Carlos's educational background also includes another Bachelor of Science (B.S.) degree in Biology from The George Washington University, although the specific years are not provided.